Lymphomatoid granulomatosis medical therapy

Jump to navigation Jump to search

Lymphomatoid granulomatosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lymphomatoid granulomatosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lymphomatoid granulomatosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphomatoid granulomatosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphomatoid granulomatosis medical therapy

CDC on Lymphomatoid granulomatosis medical therapy

Lymphomatoid granulomatosis medical therapy in the news

Blogs on Lymphomatoid granulomatosis medical therapy

Directions to Hospitals Treating Lymphomatoid granulomatosis

Risk calculators and risk factors for Lymphomatoid granulomatosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kamal Akbar, M.D.[2]

Overview

In lymphamatoid granulomatosis treatment the grade of the disease will dictate the treatment. In benign cases disease resolves spontaneously, but in other grades treatment has to be medical or surgical.

Treatment

  • There currently is a protocol being run by Dr. Wyndham H. Wilson at the NIH[1] which has had extraordinary results in which a significant percentage of participants see extended remission periods. The experimental treatment involves the use of interferons to re-set the immune system.Not always successful, this treatment is however available to anyone with an LYG diagnosis at no charge (courtesy of the NIH)

References

  1. "National Cancer Institute: Clinical Trials at NIH: Clinical Research: Clinical Trial Spotlight: Lymphomatoid Granulomatosis NCI-94-C-0074". Retrieved 2007-09-04.
  2. Makol A, Kosuri K, Tamkus D, de M Calaca W, Chang HT (2009). "Lymphomatoid granulomatosis masquerading as interstitial pneumonia in a 66-year-old man: a case report and review of literature". J Hematol Oncol. 2: 39. doi:10.1186/1756-8722-2-39. PMC 2741488. PMID 19732432.


Template:WikiDoc Sources